NCT07164378View on ClinicalTrials.gov

International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study

NANot yet recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

April 30, 2027

Conditions
Age - Related Macular Degeneration (AMD)
Interventions
PROCEDURE

Lens-Exchange

The existing IOL will be removed and replaced by implanting SING IMT™ device in the sulcus

PROCEDURE

Add-on

The SING IMT™ device will be placed in front of the existing IOL and implanted in the sulcus.

Trial Locations (11)

Unknown

Centre d'Ophtalmologie Paradis-Monticelli, Marseille

Hélios Ophtalmologie, Saint-Jean-de-Luz

CHU de Strasbourg, Strasbourg

Asklepios Augenklinik Nord-Heidberg, Hamburg

Augenklinik Sulzbach, Sulzbach

Augenklinik und Poliklinik des Universitätsklinikums, Würzburg

"Ospedale Generale Regionale F. Miulli", Bari

IRCCS Humanitas, Bergamo

Azienda Ospedaliero-Universitaria di Ferrara, Ferrara

Presidio Ospedaliero Palagi, Florence

Policlinico Universitario Fondazione Agostino Gemelli, Roma

All Listed Sponsors
lead

VisionCare, Inc.

INDUSTRY

NCT07164378 - International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study | Biotech Hunter | Biotech Hunter